Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer
著者
T. Suto, M. Ishiguro, C. Hamada, K. Kunieda, H. Masuko, K. Kondo, H. Ishida, G. Nishimura, K. Sasaki, T. Morita, S. Hazama, K. Maeda, H. Mishima, H. Ike, S. Sadahiro, K. Sugihara, M. Okajima, S. Saji, J. Sakamoto and N. Tomita
掲載雑誌名
International Journal of Clinical Oncology
学部・研究科名
医学部
抄録
URL
本サイトへの掲載日
2018-1-31
Copyright(C) Yamaguchi University Library. All rights reserved
